28 questions · 8 sources
Indication4 questions · 2 sources
Pharmacology3 questions · 2 sources
Clinical trials8 questions · 1 source
- Who was eligible for the KEYTRUDA KEYNOTE-522 trial?
- What chemotherapy was given with KEYTRUDA in KEYNOTE-522?
- Does the KEYTRUDA benefit come from treatment before or after surgery (KEYNOTE-522)?
- What were baseline characteristics in the KEYTRUDA KEYNOTE-522 trial?
- How often did KEYTRUDA plus chemotherapy leave no invasive cancer at surgery (KEYNOTE-522)?
- What was KEYTRUDA event-free survival in KEYNOTE-522?
- Does KEYTRUDA with chemotherapy lower the risk of death in early-stage TNBC (KEYNOTE-522)?
- What are the limitations of KEYTRUDA KEYNOTE-522 survival subgroup results?
Safety5 questions · 1 source
- What are KEYTRUDA side effects with chemotherapy in early-stage TNBC (KEYNOTE-522)?
- How are KEYTRUDA immune-mediated side effects managed?
- How does KEYTRUDA cause immune-mediated side effects?
- Can KEYTRUDA cause liver problems (immune-mediated hepatitis)?
- What lab monitoring does KEYTRUDA require in early-stage TNBC?